"Variations in the use of secondary CVD prevention medications over time in our contemporary cohort study suggest little to no improvement globally." HealthDay News — Use of secondary ...
Data from 17 countries show many patients with coronary artery disease or stroke do not receive medication for secondary ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback